MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recs

0
Player Avatar jigijis (< 20) Submitted: 1/14/2011 12:57:49 AM : Outperform Start Price: $9.67 MNKD Score: -85.37

A gamble

Featured Broker Partners


Advertisement